---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-001369"
form_type: "8-K/A"
ticker: "CGNX"
cik: "0000851205"
company_name: "COGNEX CORP"
filed_at: "2021-11-09T23:59:59+00:00"
generated_at: "2026-06-28T11:08:48.376085+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cognex appoints Marjorie T. Sennett to Board of Directors, declares $0.065 dividend

## Summary
- Marjorie T. Sennett appointed to Board effective Nov 3, 2021; will serve on Audit Committee.
- Sennett brings public board experience, corporate finance, biotech/tech leadership, and institutional investor background.
- Quarterly cash dividend of $0.065 per share declared, payable Dec 3, 2021 to holders of record Nov 19, 2021.
- Sennett receives $50,000 annual stipend, $10,000 for Audit Committee, plus initial RSU grant of ~$44,500 vesting over 3 years.

## SEC filing metadata
- accession: 0001157523-21-001369
- form_type: 8-K/A
- ticker: CGNX
- cik: 0000851205
- company_name: COGNEX CORP
- filed_at: 2021-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01, 2.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/851205/000115752321001369/0001157523-21-001369-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/851205/000115752321001369/a52525460.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-001369
- JSON: https://secwatch.observer/filing/0001157523-21-001369.json
- Plain text: https://secwatch.observer/filing/0001157523-21-001369.txt

## Key facts
- Executive change
  Marjorie T. Sennett was appointed as Director at COGNEX CORP.
  - Action: appointed
  - Role: Director
  source text: the appointment of a new director
  evidence_url: https://www.sec.gov/Archives/edgar/data/851205/000115752321001369/0001157523-21-001369-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.